Drawing for PS PS128

USPTO serial 79343508

PS PS128

Reviewed by CopyMark Law Group

Reg. 7383171Status 700Registered
Filing date
Status date
Registration date
May 14, 2024
Examiner
WOLD, BARBARA NIELSEN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PS PS128?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting peripheral nervous system made in whole or substantial part of Lactobacillus plantarum PS128; pharmaceutical preparations acting on the central nervous system made in whole or substantial part of Lactobacillus plantarum PS128; medicated candies made in whole or substantial part of Lactobacillus plantarum PS128; dietetic foods adapted for medical use made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for veterinary purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; Preparations of microorganisms for medical or veterinary use made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, stress, separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; nutraceutical preparations for therapeutic or medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; milk ferments for pharmaceutical purposes made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; powdered whey proteins being nutritional supplements made in whole or substantial part of Lactobacillus plantarum PS128ACTIVE—
029Yogurt made in whole or substantial part of Lactobacillus plantarum PS128; whey made in whole or substantial part of Lactobacillus plantarum PS128; milk products made in whole or substantial part of Lactobacillus plantarum PS128 namely, milk-based nutritional supplement drinks; milk ferments for culinary purposes made in whole or substantial part of Lactobacillus plantarum PS128; powdered milk made in whole or substantial part of Lactobacillus plantarum PS128; beverages having a milk base made in whole or substantial part of Lactobacillus plantarum PS128; yogurt drinks made in whole or substantial part of Lactobacillus plantarum PS128; milk solids made in whole or substantial part of Lactobacillus plantarum PS128ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 30, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 7, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 7, 2024FIMPFINAL DISPOSITION PROCESSED—
Aug 14, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 14, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 14, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 12, 2024DOCKASSIGNED TO EXAMINER—
Dec 25, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 6, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 21, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 21, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 21, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2023RFNPREFUSAL PROCESSED BY IB—
Jan 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 4, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 3, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2022DOCKASSIGNED TO EXAMINER—
Jul 5, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance